Rocket Lab (RKLB) Stock Price Prediction: Backlog growth and profit signals meet a constructive pullback
What changed
Rocket Lab (RKLB) is being priced off a stronger fundamental backdrop than a few weeks ago. On November 9, the company said third-quarter 2026 revenue hit a record level, backlog grew to $1.2 billion, it generated positive GAAP operating cash flow, and it guided to record revenue and gross margin expansion in Q4 2026. That matters because it shifts the story from a pure execution trade to one with visible operating momentum and a larger order base behind it.
The market has not ignored that update. Yahoo Finance showed RKLB at $61.53 on November 13, while the supplied market data now puts it at $59.05, down 0.81% over 24 hours. The move looks more like digestion than a full reset: the stock is still above the 20-day average of $56.56 and the Bollinger midline sits in the same area.
Analyst tape still leans positive
Analyst coverage supplied here remains constructive. Yahoo Finance listed an average target of $93.15, a high target of $127.00, and a latest Morgan Stanley rating action on November 11 that maintained Overweight while cutting the target from $105 to $103. TipRanks also cited Morgan Stanley’s Kristine Liwag as Overweight with a $103 target, framing the post-earnings move as a reaction to the company’s latest results and contract backlog. Aries shows 20 analysts with a consensus that 80% rate the stock a buy, and a 12-month average target of $97.34.
The key point is not that every target implies immediate upside, but that the analyst base is still anchoring expectations well above where the shares trade now. That supports the idea that the market is still discounting execution risk around Neutron while also paying for backlog conversion and margin expansion.
Technical setup: constructive, but not cleanly impulsive
The tape is mixed, not euphoric. RKLB’s daily RSI is 51.90, which is neutral. MACD is positive at 0.7654 with a flat histogram, suggesting momentum is not accelerating hard in either direction. Stochastic readings are mid-range, not stretched.
The moving-average structure is better than the near-term price wobble suggests. The 7-day SMA at $61.44 is above the 20-day SMA at $56.56 — an early bullish recovery. Price is also above both the 20-day average and the 12-day EMA at $58.65, though still below the 50-day SMA at $60.08 and just under the 7-day average. That puts the shares in a tight band where the next move matters more than the last one.
On the level map, $61.01 is immediate resistance and $62.98 is stronger resistance. Support sits at $57.88 first, then $56.72. The pivot point is $59.85, essentially where the stock is trading now. With ATR(14) at $4.93, RKLB has enough daily range to move through those levels quickly if volume returns.
Derivatives positioning: mildly supportive, but not a clean confirmation
Binance perpetual futures data points to a cautiously positive bias, but not a decisive one. The funding rate is neutral at 0.0000%, so traders are not paying up aggressively to stay long. Open interest is 89,155.26 contracts, with daily open interest value at $5.31 million and a 3.42% decline over 24 hours, which suggests some position reduction rather than fresh leverage build.
The long/short ratios lean long. Binance global accounts show 65.7% long versus 34.3% short, while top-trader accounts show 72.0% long versus 28.1% short. That is constructive positioning, but it should be read as Binance cohorts, not a proxy for broader shareholder conviction. The taker buy/sell ratio of 0.8376, with buy volume of 11,608 against sell volume of 13,858, argues that aggressive flow has recently been heavier on the sell side.
What would improve the setup
The bullish case strengthens if RKLB can reclaim and hold above $61.01, then challenge $62.98 with volume. A break through that band would put the stock closer to the upper Bollinger area at $65.54 and would tell traders the post-earnings consolidation is resolving higher rather than fading.
The downside case is cleaner too. If the stock loses $57.88, the next support at $56.72 comes into view quickly, and a failure there would hand control back to the 20-day average area rather than the recent recovery structure. With the current setup, the market is still deciding whether the earnings gap and backlog news become a new base or just a sharp reaction that cools off.